Zdrowie i gospodarka · 05/09/2017
FDA Clears Path for ENJUVIA Tablets to be Approved
The FDA has determined that ENJUVIA tablets, 0.625 mg and 1.25 mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →